CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 32 enrolled
Drug / intervention
Anti-Hypertensivedrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05479097
NCT05479097N/ACompleted

A Feasibility Study of a Novel mHealth Clinical Decision Support Application to Enable Community Health Workers to Manage Hypertension With Remote Physician Supervision

University of Wisconsin, Madison·interventional·Posted Jul 29, 2022·Updated Jul 16, 2024

In Brief

A clinical study evaluating Anti-Hypertensive for Hypertension. Completed, enrolled 32 participants across 1 site.

Detailed Summary

This is a single group study assessing the feasibility of hypertension management by community health workers (CHWs) equipped with a mobile clinical decision support (CDS) application and working with remote physician supervision.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHypertension
CountriesGuatemala

Timeline

N/ACompletedFinished
2023202420252026
First PostedJul 29, 2022
Enrollment StartFeb 6, 2023
Primary CompletionAug 15, 2023
Study CompletionDec 31, 2023
TodayJul 2, 2026
Enrollment to primary: 6 monthsPosted 3.9 years ago

Interventions

Anti-Hypertensivedrug

Based on information entered by the CHWs into the CommCare application designed for this study, the application will provide recommendations (and underlying rationale for these recommendations) for prescription of antihypertensives (amlodipine and/or losartan OR enalapril) and medications to reduce cardiovascular risk (aspirin and atorvastatin) if indicated, lifestyle modification, and referral to the supervising physician if indicated for potential complications of hypertension.